Enanta Pharmaceuticals (ENTA) Capital Expenditures Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -81.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -81.54% |
| Dec 31, 2025 | -64.35% |
| Sep 30, 2025 | 179.44% |
| Jun 30, 2025 | -245.91% |
| Mar 31, 2025 | 86.54% |
| Dec 31, 2024 | 475.00% |
| Sep 30, 2024 | 150.46% |
| Jun 30, 2024 | 147.25% |
| Mar 31, 2024 | 134.11% |
| Dec 31, 2023 | 61.17% |
| Sep 30, 2023 | 142.86% |
| Jun 30, 2023 | 124.54% |
| Mar 31, 2023 | 102.37% |
| Dec 31, 2022 | 86.31% |
| Sep 30, 2022 | 21.20% |
| Jun 30, 2022 | -51.72% |
| Mar 31, 2022 | -37.31% |
| Dec 31, 2021 | -67.20% |
| Sep 30, 2021 | 157.48% |
| Jun 30, 2021 | 36.65% |
| Mar 31, 2021 | -51.58% |
| Dec 31, 2020 | 19.20% |
| Sep 30, 2020 | -35.26% |
| Jun 30, 2020 | -36.47% |
| Mar 31, 2020 | -38.48% |
| Dec 31, 2019 | -20.00% |
| Sep 30, 2019 | 27.66% |
| Jun 30, 2019 | 53.80% |
| Mar 31, 2019 | 1.60% |
| Dec 31, 2018 | -15.96% |
| Sep 30, 2018 | -69.92% |
| Jun 30, 2018 | -70.65% |
| Mar 31, 2018 | 125.39% |
| Dec 31, 2017 | -24.31% |
| Sep 30, 2017 | -21.57% |
| Jun 30, 2017 | 25.15% |
| Mar 31, 2017 | 60.04% |
| Dec 31, 2016 | 241.16% |
| Sep 30, 2016 | -172.56% |
| Jun 30, 2016 | 127.59% |
| Mar 31, 2016 | 64.32% |
| Dec 31, 2015 | 484.54% |
| Sep 30, 2015 | 142.35% |
| Jun 30, 2015 | 104.17% |